Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients

por van de Berg, S. E. J., Pelzer, P. T., van der Land, A. J., Abdrakhmanova, E., Ozi, A. Muhammad, Arias, M., Cook-Scalise, S., Dravniece, G., Gebhard, A., Juneja, S., Handayani, R., Kappel, D., Kimerling, M., Koppelaar, I., Malhotra, S., Myrzaliev, B., Nsa, B., Sugiharto, J., Engel, N., Mulder, C., van den Hof, S.
Publicado 2021